*Correspondence: Shailendra Pratap Singh, [email protected] ORCID: sapna tiwari, orcid.org/0009-0000-5282-0324 Anjali Gupta, orcid.org/0009-0006-4759-9315 Deepa Pandey, orcid.org/0009-0005-0951-6761 Priyul Pandey, orcid.org/0009-0008-7084-2824 Rinkesh Gupta, orcid.org/0009-0006-9779-3618 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
High-dose antioxidant supplements (vitamins C and E in megadoses) lack evidence for benefit in diabetes management and may interfere with certain laboratory tests or medications
Hormone replacement therapy (HRT) and GLP-1 weight loss medications, like Wegovy and Zepbound, are now being considered as complementary treatments that can help manage menopausal weight gain when used together
The study was funded by the National Institute of Child Health and Development (grant R01 HD097778)
Institutional systems continue to favor Rx-classified nutritional therapies, which account for 81.6% of hospital-based supplement distribution